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HURAIAN MEKANISME ANTIPROLIFERASI EKSTRAK METANOL 




Kanser adalah antara punca kematian di seluruh dunia. Matlamat utama rawatan 
kanser ialah untuk membuang sel malignan sepenuhnya tanpa merosakkan sel 
normal. Penemuan penawar yang selamat dan berkesan untuk kanser dengan kadar 
yang segera adalah sangat diperlukan dan ianya kekal menjadi cabaran besar pada 
masa kini. Dalam sejarah perubatan, tumbuhan herba telah terbukti menjadi salah 
satu sumber berharga dalam merawat kanser seperti Dendrophthoe pentandra (DP). 
Dikenali sebagai dedalu, tumbuhan ini merupakan tumbuhan separa parasit dengan 
latar belakang perubatan tradisional untuk merawat kanser. Namun begitu, 
mekanisme yang menjadi asas kepada aktiviti antikanser adalah tidak jelas. Oleh itu, 
DP telah dipilih untuk memahami aktiviti antiproliferasi dan mekanisme kematian 
sel dalam rawatan kanser tersebut. Pengekstrakan DP menggunakan pelarut metanol 
(DPME) telah dijalankan. DPME dinilai bagi mengetahui sebatian fitokimia yang 
hadir. Tannin hadir sebagai sebatian fitokimia yang paling banyak terdapat dalam 
DPME. Aktiviti antiproliferasi oleh DPME terhadap HeLa, MCF-7, MDA-MB-231, 
HepG2 dan U-2 OS telah dinilai oleh MTT Asai dan graf tindak balas dos 
kemudiannya diplot untuk menentukan nilai IC50. Sel MCF-7 menunjukkan 
perencatan pertumbuhan yang paling berkesan dengan nilai IC50 terendah apabila 
dirawat dengan DPME. Aktiviti sitotoksisiti terhadap sel buah pinggang yang 
normal, MDCK dan sel fibroblast yang normal, L-929 juga dinilai untuk menentukan 
kesan sitoselektif oleh DPME. Pewarnaan nukleus oleh Hoechst 33258 menunjukkan 
xiii 
 
kondensasi kromatin, fragmentasi nuklear dan pembentukan badan apoptotik apabila 
dirawat dengan DPME mengikut tempoh masa tertentu. Analisis flowsitometri 
mengesahkan bahawa rawatan DPME menghalang proliferasi sel MCF-7 apabila 
perkembangan kitaran sel terhenti pada fasa G1/S. Mekanisme MCF-7 kematian sel 
yang disebabkan oleh DPME melalui tapak jalan apoptosis telah dinilai oleh 
pewarnaan berganda Annexin V-FITC dan propidium iodida. Kajian ini juga 
mendapati bahawa mekanisme apoptosis tersebut telah dicetuskan oleh DPME 
melibatkan pengawalaturan tumor p53 protein penindas yang membawa kepada 
pembebasan cytochrome C. Mekanisme tapak jalan apoptosis juga berkaitan dengan 
perencatan protein antiapoptotik, Bcl-2 dan pengaktifan protein proapoptotik, Bax. 
Kesimpulannya, DPME menunjukkan aktiviti antiproliferasi sel MCF-7 secara 
aruhan kematian apoptosis dan ini membuktikan pendekatan yang positif untuk 
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Cancer is one of the major causes of death, worldwide. The ultimate goal of cancer 
treatment is to remove the malignant cells completely without harming healthy cells. 
There is an urgency to find a safe and highly effective treatment for cancer disease 
and it remains a big challenge nowadays. Throughout medical history, herbal plants 
have been shown to be one of valuable sources in combating cancer such as 
Dendrophthoe pentandra (DP). DP or Mistletoe is a semi-parasitic plant with 
traditional claims for anticancer property. However, the mechanism underlying 
anticancer activity is unclear and need to be explored. Therefore, DP was selected in 
order to evaluate its antiproliferative activity and mode of cell death in cancer 
treatment. The extraction of DP leaves were carried out using methanol (DPME) by 
maceration technique. Phytochemicals compound present in DPME were screened 
and quantified. Tannin is the most abundance phytochemical present in DPME. The 
antiproliferative activities of DPME towards HeLa, HepG2, MCF-7, U-2 OS and 
MDA-MB-231 cell lines have been examined by MTT Assay and IC50 values were 
obtained. MCF-7 cells showed the most effective growth inhibition with lowest IC50 
value upon treatment with DPME. The cytotoxicity activities towards normal kidney 
MDCK and normal fibroblast L-929 cells were evaluated to determine the 
cytoselectivity property of DPME. The nuclear staining by Hoechst 33258 displayed 
the chromatin condensation, fragmented nuclei and formation of apoptotic bodies 
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upon treatment with DPME according to certain period of time. Flowcytometric 
analysis using Annexin V/PI double staining has confirmed that DPME-treated 
MCF-7 arrested cell cycle distribution at G1/S phase and induced apoptosis. The 
mechanism of action was further confirmed by determination of protein involved in 
apoptosis pathway; Bcl-2, Bax, p53 and cytochrome C. The results found out that the 
increased of p53 was followed by an increment of pro-apoptotic, Bax and decreased 
of anti-apoptotic, Bcl-2. Activation of Bax and inactivation of Bcl-2 triggered release 
of cytochrome C which leads to apoptosis event. In conclusion, DPME demonstrated 
antiproliferative activity in MCF-7 cells by induction of apoptosis. Therefore, DP has 










1.1 Background of study 
 
In general, recent trends showed that Malaysia as a developing countries is 
going through rapid transformation of social life and economic changes. This 
situation has led to a typical lifestyles improvement that usually occur to other 
industrialized countries. In consequences of the situation, there are rising cases of 
cancers associated with reproductive and dietary (International Agency for Research 
on Cancer, 2013). The report also stated that aging and growth of the global 
population would affect some significant increase up to 19.3 million new cancer 
cases per year by 2025.  
 
World Health Organization (WHO) stated that breast cancer is a common 
cancer among women worldwide (National Breast Cancer Foundation, 2015). Every 
year, the lives of thousands females has been threaten due to breast cancer. 
Pathological assessment of the breast cancer should be evaluated routinely since it is 
essential for accurate decision making upon treatment. Usually, breast cancer 
patients encountered certain side effects of treatment such as infertility and early 
menopause. Fear of reoccurrence and physical appearance also one of the 
physiological issue faced by breast cancer patients. Since 2008, Malaysia has 
experienced in increment of breast cancer prevalence by more than 20 % and death 
was up by 14 % (Fernandez, 2014). Public awareness about breast cancer are still 
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poor and below par. Lack of cancer awareness and incapability to seek basic health 
care are among major obstacle to optimum cancer care (Yusof, 2013a). This scenario 
also had been attributed to a robust faith toward traditional claim on effectiveness of 
herbal medicine, the negative perception of the disease as well as poverty and poor 
education (Hisham and Yip, 2004).  
  
1.2 Rationale of study 
 
One of the most common cancer type in Malaysia is breast cancer. Surgery 
remain the most common option for breast cancer treatment with the help of 
radiotherapy as well as chemotherapy. Surgery such as mastectomy is a crucial 
process due to certain disfiguring operation. The cost, access and fear of further 
surgery remain as remarkable hindrance in these type of breast cancer treatment. 
Chemotherapy has been proved to alter survival in women with breast cancer. 
However, there are certain cases where the patient’s immune system has been 
compromised with this treatment (Yip et al, 2014). Effectiveness and side effects of 
chemotherapy, surgery and radiation are limited by toxicity effects to healthy tissues 
in body and costly operation.  
 
Most common alternative medicine for treatment of cancer are dietary 
supplements, Malay traditional medicine and followed by praying (Shaharudin et al, 
2011; Yip et al, 2014). Usage of traditional medicine such as herbal medicine have 
been utilized extensively by many Malaysian to improve survivorship regardless of 
scanty evidence of their effectiveness (Soon et al, 2009; Benzie and Wachtel-Galor, 
2011; Sooi and Keng, 2013). There is an overwhelming interest in search for herbal 
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plant-derived anticancer agents since the old folks believed that they are less toxic. 
Therefore by consuming herbal medicine, it probably can reduce toxicity effect of 
commercial medicine on human (Abdullah et al, 2013; Shaharudin et al, 2011; Boik, 
1996). This proved that there is an urgency to find a safe and highly effective cure 
for cancer disease.  
 
With this current situation, it is important to establish as well as initiate 
clinical trials especially for the common herbal medicine that has been utilized 
locally. In this research, Dendrophthoe pentandra (DP) has been chosen based on 
traditional claim from old folks and previous research that identified D.pentandra 
methanol extracts (DPME) has highest total phenolic content compared to water 
extract and petroleum ether extract of DP (Dasuki et al, 2012). DP come in abundant 
source, easily available and it is already been utilized in certain other action as 
medicinal plant. DP is considered as unwanted plant to economically important 
horticultural plant (Artanti et al, 2012). Since targeting apoptosis which is one of a 
good alternative strategy for cancer prevention and treatment, the potential of DP as 
an anticancer agent towards breast cancer, its mechanism and basic phytochemical 
profile have been reported throughout this study. Although there are several research 
reported on the potential of DP as an anticancer agent but the studies regarding the 
phytochemical profile, antiproliferative effect and its mechanism of cell death has 
not yet been fully elucidated.  
 
The findings of this research could have provide guidance and support the 
traditional knowledge of local people in using DP for cancer treatment especially 
breast cancer. It is also could deliver new knowledge about certain new species of 
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herbal plant that having medicinal properties of anticancer. With increasing concern 
of cancer chemoprevention from herbal medicinal plant, the utilization of unwanted 
part of medicinal plant in Malaysia such as DP might have beneficial effect towards 
cancer treatment. The mechanism of action of DP extract towards human breast 
carcinogenesis can be used as a guide for future medicinal practice in the treatment 
of breast cancer as apoptosis has been plays a vital task in developmental processes, 
maintenance of homeostasis and removal of damaged cells.  
 
1.3 Objectives of study 
 
1.3.1 General objective 
 
The general objective for this research is to evaluate the antiproliferative effect of 
DPME and identify its mechanism of action as a potential anticancer agent.  
 
1.3.2  Specific objectives 
 
The specific objectives of this research study are:  
1. To evaluate the phytochemical compounds of DPME using qualitative and 
quantitative analysis.  
2. To investigate antiproliferative activity of DPME-treated on selected cancerous 
cell lines.   
3. To determine the cell cycle arrest in the cell line that showed most effective 
inhibition by DPME 
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4. To confirm the mechanism of cell death for the cell line that showed most 
effective inhibition by DPME-induced apoptosis pathway, with observation of 












Cancer has been associated as major factor of death in the world. In 2013, 
International Agency Research on Cancer (IARC), the specialized cancer agency of 
the World Health Organization in its online database, GLOBOCAN, reported that 
more than 14 million new cancer cases and almost 10 million cancer-related deaths. 
Compared to 2008, there were approximately 12.7 million new cases and 7.6 million 
deaths related to cancer cases. The report also disclosed that lung cancer was the 
most commonly diagnosed cancers worldwide, followed by breast and colorectal. 
More than half of all cancer cases which is 56.8 % and cancer deaths which is 64.9 % 
in 2012 alone, occurred in non-industrialized countries in the world. These 
percentage has been predicted to be increase by the year 2025 (International Agency 
for Research on Cancer, 2013).  
 
In Malaysia, there are about 37, 000 new cancer incidents and 22, 000 cancer 
deaths were reported throughout the whole nation, every year (Fernandez, 2014). 
Based on this statistical data, National Cancer Society Malaysia (NCSM) foresaw 
that there will be more Malaysians diagnosed with cancer in upcoming years. 
Developing countries such as Malaysia will bear the burden when there is an 
estimation more than 20 million new cancer incidents arises yearly by 2030.  
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2.2 Breast cancer  
 
Breast cancer is among major causes of deaths worldwide that has provoked 
40, 000 lives in 2013 (Majumdar et al, 2014). Breast cancer has been reported as 
most frequent diagnosed cancer among women in 140 out of 184 countries. This 
scenario can be regarded as 1 : 4 of all cancers diagnosed in women (International 
Agency Research on Cancer, 2013). In Asia countries including Malaysia, the 
prevalence of breast cancer was reported increased. (Park et al, 2011; Abdullah et al, 
2013).  
 
In Malaysia, breast cancer is one of three common cancer cases in Malaysian 
women (Dahlui et al, 2011). The International Agency for Research on Cancer 
estimated that age-standardised rate of breast cancer in Malaysia as 38.7 per 100, 000 
with 5, 410 new cases (Yip et al, 2014). By comparing Malaysian women and 
women in Western countries, the breast cancer case present at earlier age in 
Malaysian women. This happened could be due to Malaysia has a younger 
demographic with median age of 26 years old, compared to 39.8 years old in United 
Kingdom. As reported by Abdullah et al (2013), patients with breast cancer were 
mostly Malay (53.8 %) followed by Chinese (27.1 %) and Indian (9.6 %). From all 
of above alarming situation, there is an urgent need to prevent increment of breast 
cancer case by developing potent and economical approaches for the early detection 





2.2.1 Characteristics and classification of breast cancer cells   
 
Generally, each type of cancer cells can be distinguished into 3 main 
categories, by the cells which it originates (Kleinsmith, 2006). Firstly, carcinomas 
that appears from epithelial cells which form covering layers of external and internal 
body. Secondly, sarcomas which originates in supportive tissue such as bone and 
muscles. The last one is correlated with lymphoma and leukaemia. The lymphoma 
can be defined as lymphocytes cancer which mainly grow as solid masses of tissue. 
The leukaemia can be simplified as cancers in blood cells that grow rapidly in 
bloodstream. Breast cancers are mostly carcinomas that initiates in the epithelial cells 
of breast organ. Other than that, it could originates in glandular tissue of breast and it 
is known as adenocarcinoma. 
 
Despite origin sites of cancer, each type of cancer behaves differently. 
Cassidy et al (2010) reported that characteristics of cancer cells are including 
proliferation in the lack of growth factors, failure to respond to normal brakes on 
proliferation; for example growth inhibitors, cell cycle control check points, 
resistance to apoptosis and senescence, ability to invade surrounding tissues and 
metastasize and ability to recruit blood vessels. Normal cell growth showed well-
mannered balance between promoting and restraining signals so that the proliferation 
happened only when required. This balance is tilted when increased cell numbers are 
required. Differentiation of the cells during this process take places in proper 
regulation and proliferation discontinues when no longer needed (Cassidy et al, 
2010). Cancer cell growth showed distortion of above process where cell keep on 
proliferate continuously and causing loss of differentiation could be seen clearly. 
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Cancer itself can be defined as a pathological disturbance of growth, characterized by 
excessive and unnecessary proliferation of living cells (Elmore, 2007).  
 
Breast cancer cells can be classified as either benign or malignant (Table 2.1). 
Benign breast cancer are generally slow-growing expansive masses that grow and 
compress in a confined local area rather than invade surrounding tissue of healthy 
breast cells. They are often encapsulated, grow by expansion and does not invade or 
spread to nearby tissue (Kleinsmith, 2006). However, there are some benign cancer 
that could have malignant potential and these should be removed before malignancy 
develops thus thrusts on vital structures such as nearby blood vessels or nerves. In 
other cases, breast cells may grow, invade surrounding and divide with complete 
disregard for the needs of the body which is called malignant cells. These type of 
cancer are potent to grow into large masses known as lumps and spread to other areas 
of the body becoming metastases. Metastases means the development of secondary 
malignant growth at a distance from a primary breast cancer site. This condition 
allow the malignant breast cells continues to grow rapidly without any limitation. 
Generally, these types of cells are not encapsulated, tend to infiltrate, invade and 
destroy surrounding tissue. Malignant breast cancer are able to colonize other organ 













Table 2.1 Some properties of benign and malignant cancers (summarized from 
Kerr et al, 1972; Elmore, 2007; MacDonald et al, 2004; Kamal, 2014). 
 Benign Malignant  
Growth Pattern Local growth only Spreads by invasion and 
metastasis 
Life Threatening Rare Often 
Proliferation Slow Rapid 
State of 
differentiation 













2.2.2 Treatment of breast cancer 
 
In general, treatment of cancer is a multidisciplinary effort. It depends on the 
locality of cancer, cancer categories and stages of the disease which include whether 
it is metastasis or not. Based on this factor, most cancer can be treated and cured. The 
histology examination of cancer tissue are usually performed whenever definitive 
diagnosis are carried out. Once the definitive diagnosis are done, the cancer is 
usually treated with incorporation of operation, chemotherapy and radiotherapy. 
Besides that, hormonal therapy, immune therapy, monoclonal antibody therapy, 
supportive therapy and symptomatic therapy can be considered (Acton, 2013). 
Currently, the treatments becomes particular for that type of cancer pathologically, 
and in this study, particularly towards breast cancer cells. The ultimate aim of any 
cancer treatment is to remove the cancer tissue completely without affected to the 
rest of the body. To remove the cancer with the goal to reduce the risk of 
reoccurrence of diseases can be such a major problem to achieve. 
 
The most common method for breast cancer treatment is surgery. Majority 
patients with breast cancer diseases choose surgery as their first treatment. However, 
the limitation of this option is the tendency of cancers to invade nearby tissue and 
spread to distant location by microscopic metastatic. Patient with invasive breast 
cancer are offered to be treated with chemotherapy or hormonal therapy to shrink the 
cancer prior to surgery (National Breast Cancer Foundation, 2015).  
 
Other than that, hormone therapy also should be considered if belongs to 
hormone receptor positive (Acton, 2013). Otherwise, if the cancer cell is hormone 
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receptor negative, then this therapy have no benefit for patient in treatment of cancer 
disease. Hormone therapies function by blocking the effect of hormones on breast 
cancer cells. There are patients that have been given hormone therapy before the 
surgery was carried out due to reduce size of the cancer or if surgery is not an option 
for the patients. Anastrozole, letrozole, exemestane and goserelin are the hormone 
therapy drugs commonly used to treat primary breast cancer (National Cancer 
Institute, 2015). 
 
Another common option in combating breast cancer disease is radiotherapy. 
This treatment utilizes high energy x-rays to demolish cancer cells that left at the 
breast area after surgery. Radiotherapy has been given to lessen the risk of the cancer 
returning in the breast. Magnetic radiation imaging (MRI) is an example of new 
diagnostic tool for breast cancer treatment in Malaysia. However, MRI is not suitable 
for routine screening even though it is also practical to differentiate between 
malignant and benign breast tumor (Hisham and Yip, 2004). This types of radiation 
can cause damage to normal tissue and affects healthy cells. Damage to non-
cancerous cells can be reduced by providing small doses frequently which eventually 
can increase the time for cancer treatment to accomplish.  
 
Apart of that, the targeted therapy has been used by blockage of cancer 
growth through inhibiting specific molecules that involved in growth of cancer cells 
(Yusof, 2013b). For example, molecule known as HER2 protein that present 
excessively in breast cells lead to disorderly growth thus promoting the formation of 
malignant cells. The drug known as trastuzumab acts against HER2 protein. It is 
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considered as an ideal therapy for HER2 positive breast cancer. The main 
disappointment is the treatment with trastuzumab involved high cost (Yusof, 2013b). 
 
Chemotherapy is a treatment using anticancer drug that behaving as cytotoxic 
drugs. It can be provided before surgery which referred as neo-adjuvant 
chemotherapy or after surgery which known as adjuvant chemotherapy. The neo-
adjuvant can helps in reducing the size of a cancer. There are many different types of 
chemotherapy. The chemotherapy drugs can be utilized in several different 
combinations or as individually. It also can be given intravenously or orally. 
However, the effectiveness of chemotherapy is often limited by toxicity to other 
tissues in the body. The usage of chemotherapy drugs are controversial, mainly 
related to drugs resistance where the immune system of patients has been used with 
chemotherapy routine treatment (Yip et al, 2014). The most common side effects are 
nausea, sore mouth, hair loss or thinning and tiredness. 
 
The most ubiquitous chemotherapy drugs for breast cancer treatment is 
tamoxifen, which have been widely used as antiestrogen. Since 1973, tamoxifen has 
been used since 1973 as an adjuvant therapy (Osborne, 1998). It has been accepted 
by Food and Drug Administration (FDA) in 1977 to treat both early and later stages 
of breast cancer. Almost 70 % of all breast cancers cases are categorized as estrogen 
receptor alpha positive (Dixon, 2014). However, patients that undergo treatment with 
tamoxifen is developing a risk towards endometrial cancer (Fisher et al, 1994) due to 
genotoxic DNA damage (Kim et al, 2004). Growth of some cancer may initially be 
weakened by treatment of tamoxifen but become immune to continued treatment 
(Clemons et al, 2002). Early Breast Cancer Triallists’ Collaborative Group (2005) 
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reported that one third of breast cancer patients which have been treated with 
tamoxifen for 5 years will have reoccurrence within 15 years. Although there are 
many cancer respond to chemotherapy drugs, breast cancer cells eventually build 
resistance towards chemotherapy. The hitch of treatment with chemotherapy have 
pave the way for alternative drugs that grant maximum effect and are less harmful 
for cancer treatment (Yaacob et al, 2013).  
 
2.3 Mechanism of cell death 
 
Inhibition of cell proliferation that have been induced by certain agents which 
cause cell death can be simplified as antiproliferative activity. Mode of cell death can 
be implemented through apoptotic, necrotic death, aging and so on. There is certain 
overlap properties between these apoptosis and necrosis even both of mechanism are 
different (Elmore, 2007). Therefore, it is really important to utilize more than one 
distinguishable assay to confirm the mechanism of cell death that occurs in the 
pathway. It has become a general routine involving early detection of apoptotic 
events and another detection could target for later execution event, which this later 
assay can be double check the presence of apoptosis.  
 
2.3.1 Necrosis  
 
Necrosis is a toxic process where the cells are put in passive situation, 
uncontrolled and energy-independent mode of death. In necrotic cell death, external 
factors such as hypoxia, excessively high concentration of chemical toxins and injury 
could damage the cell irreversibly. During necrosis, there are changes of cell 
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morphology. The cell swelling, formation of cytoplasmic vacuoles, formation of 
blebbed cytoplasm and condense swollen mitochondria are among typical 
morphological changes that occur in necrosis (Kerr et al, 1972; Elmore 2007; Zakaria 
et al, 2009). There is an influx of water and ions after which the cells and its 
organelles swell and rupture. Necrotic cell lysis induces acute inflammatory 
responses owing to the release of lysosomal enzymes into extracellular environment. 
Lysosomal proteases released into the cytosol cause widespread degradation. There 
is a rise in cytosolic calcium, increased reactive oxygen species (ROS), intracellular 




 Apoptosis is tightly controlled and energy-dependent process (Fridman and 
Lowe, 2003). It is a normal genetically programmed process that occurs during 
embryonic development, maintenance of tissue homeostasis for cell population, 
under pathological conditions and aging process. It is originally called shrinkage 
necrosis, it was renamed apoptosis as ‘dropping off as leaves from tree’ (Kerr et al, 
1972; Elmore, 2007). Morphological changes that occur during apoptosis can be 
identified by light and electron microscope. During early apoptosis, the breakdown 
of nucleus occur. This include the chromatin condensation and DNA fragmentation 
that are visible under light microscope. When this happened, the organelles are more 
tightly packed and plasma membrane blebbing occurs followed by cell fragmented 
into apoptotic bodies. Apoptosis has specific characteristic features of membrane-
bound vesicles called apoptotic bodies and absence of inflammatory response 
(Elmore, 2007) due to phagocytosed by surrounding cells (Kurosaka, 2003). There 
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are no inflammatory reaction during process of apoptosis since there are no release of 
cellular contents to nearby tissue. The apoptosis event eliminates cancerous cell 
without damaging normal cells and surrounding tissues (Rahman et al, 2013). Table 

























Table 2.2 Comparison of apoptosis and necrosis (summarized from Elmore, 
2007; Rang et al, 2007; Kumar and Clarks, 2012)    
Apoptosis Necrosis 
Programmed cell death Uncontrolled cell death 
Single cells or small clusters of cells Often contiguous cells 
Cell shrinkage and convulation Cell swelling 
Intact cell membrane Disrupted cell membrane 
Cytoplasm retained in apoptotic bodies Cytoplasm released 
No inflammation  Inflammation usually present 
Non – toxic process Toxic process  
Non – degradative process Degradative process  
Active process Passive process  












Apoptotic cells display a few number of biochemical modifications such as 
protein cleavage and DNA breakdown (Hengartner, 2000). The mechanisms of 
apoptosis pathway involves an energy-dependent cascade of molecular events 
(Elmore, 2007). Many chemotherapy and radiotherapy regimens work by triggering 
apoptotic pathways in the cancer cells (Kumar and Clarks, 2012). These common 
regimens cause DNA damage in cells which lead to apoptosis event through a p53-
dependent pathway (Elmore, 2007). There are two main signalling pathway involve 
in apoptosis which are extrinsic and intrinsic pathways. Rang et al (2007) reported 
that extrinsic pathways is known as death-receptor pathways signals from outside of 
the cell whereas intrinsic apoptotic pathways or popularly known as mitochondrial 
pathways signed for internal signals such as DNA damage. The extrinsic pathway 
that commence apoptosis involve transmembrane receptor-mediated interactions 
(Elmore, 2007). These involve death receptors that are members of the tumour 
necrosis factor (TNF) receptor gene. Members of TNF bind to extrinsic ligands and 
transduce some intracellular signals that cause destruction of the cell (Elmore, 2007). 
The extrinsic pathways can be amplified by induction of the intrinsic pathway.  
 
The intrinsic apoptotic pathway can be distinguished by membrane 
permeability that causes mitochondrial swelling, rupture of outer membrane and 
release of pro-apoptotic factors (Kwon and Kalimuthu, 2013). The intrinsic pathway 
involves various non-receptor mediated intracellular signals and triggered cellular 
activities in mitochondria thus leads to apoptosis event. Cellular stresses such as 
growth factor withdrawal, p53-dependent cell cycle arrest and DNA damage induce 
expression of pro-apoptotic proteins, Bax and cytochrome C (Elmore, 2007). p53 has 
been named ‘the guardian of the genome’ due to its crucial role in protecting the 
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integrity of genetic information in response to various genotoxic injuries (Moll et al, 
2005; Wong et al, 2013). Activation of apoptotic event by p53 is tightly regulated. 
Disruption of apoptosis activation can promote tumor progression, allowing the 
continual of cell proliferation and chemoresistance. The p53 activate DNA repair 
proteins when DNA has sustained damage, arrest growth of cancer cells at a 
checkpoint for DNA damage repair thus cause cells undergo apoptosis if the damage 
remained (Pietenpol and Stewart, 2002). As a transcription factor, p53 stimulates 
apoptosis though the transcription and regulation of its target genes such as Bcl-2 
family members (Fridman and Lowe, 2003). This is due to cancer cells can build 
resistance towards apoptosis by the expression of anti-apoptotic proteins or by down-
regulation of pro-apoptotic proteins.  
 
2.4 Cell cycle  
 
A cell actively proliferates and passes in and out of cell cycle. During cell 
proliferation, DNA replication and cell division are two important activities that 
occurred (Li et al, 2007). The DNA replication has to be ended before cells divide. 
Theoretically, cells division or known as mitosis resulting formation of two cells. 
Both cells received a complete copy of genome with all vital genetic information 
(Hung et al, 1996). Cell cycle has been divided into four sequential phases which is 
G1, S, G2 and M phase. The G1 defined as first gap phase that allow cell to prepare 
for another round of DNA replication. It is an evaluative point where “cell decide” 
whether should enter the cell progression or not. The S phase or known as the period 
of DNA synthesis occurred. In this phase, enzymes such as DNA polymerases, 
primases, helicases and topoisomerases are assemble to duplicate the genome (Hung 
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et al, 1996). The G2 phase is the second gap phase that allow cell to prepare for cell 
division. The M or mitosis is a phase where DNA segregation occur and the cell 
divide into new cells that genetically similar. Pietenpol & Stewart (2002) stated that 
the gaps between the end of cell division and DNA synthesis starts known as G1/S 
checkpoint whereas between DNA synthesis and mitosis begins known as G2/M 
checkpoint. These checkpoints signalling are important to ensure a proper sequence 
and timing of events.  
 




Herbal medicines can be defined as traditionally and naturally occurring, 
plant-derived substances with minimum or none involvement of any industry that 
intended to cure illness through therapeutic practices (Tilburt and Kaptchuk, 
2008). Herbal plant have been used by human being since ages in traditional and 
complementary medicines due to their therapeutic potential. Herbal medicines 
nowadays are really popular to the public (Kennedy and Seely, 2010) and has been 
commonly used for various treatment of diseases and enhancement in quality of life 
(Benzie and Wachtel-Galor, 2011). The World Health Organization (2016) reported 
that approximately 80 % of the world population depend on herbal plants for their 
first-line medicines. Including Malaysia, the usage of herbal medicine as alternative 




Herbal medicines are derived from various parts of herbal plants. It can be 
processed in different ways and formed into teas, ointments, rubs, tablets, essential 
oils, syrup and tablets that contain powdered form of herbs or its dried extract 
(Benzie and Wachtel-Galor, 2011). Old folks believed that the various form of herbal 
preparation can be utilised for treatment of chronic disease and diverse ailments. The 
biological activities of herbal plant may varied when different technique of extraction 
has been utilised during the herbal preparation. This may be due to herbal 
preparation contain natural compounds with different technique of extraction that 
may release certain remarkable biological activities. Among the common reason for 





In many countries, herbal medicines are not regulated as extensively as 
conventional medicine. In Malaysia, the usage of herbal medicines are mostly based 
on ethnic beliefs and ritual observation (Sooi and Keng, 2013). Many of herbal 
medicines claim to offer relief and prevention of adverse health conditions (Ibrahim, 
2004). Comparing to the commercially available pharmaceutical medicine, majority 
of Malaysian believed that the content of herbal medicine does not harmful and free 
from side effects (Soon et al, 2009). More than 75 % of Malaysian females 
considered herbal medicines safe and effective due to herbs contain natural 
substances (Sooi and Keng, 2013). This elevation trend of prevalence regarding 
usage of herbal medicines in Malaysia may probably due to the assumption that 
herbs are safe to be utilized. There is concern for the lack of standardization of herbal 
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preparations to guarantee their safety, quality and efficacy (Ibrahim, 2004). This 
awareness is due to certain herbal may be contaminated and degraded during the 
herbal preparation (Benzie and Wachtel-Galor, 2011). Actual knowledge of herbs, 
information related to dosage and their properties should be established. To ensure 
quality, consistency and safety, the herbal preparation need to be replaced with more 
accurate and reproducible ways. Thus, there is an immediate need to improve the 
safety knowledge of herbal medicine with proper documentation.  
 
2.6 Herbal medicine and breast cancer 
 
From the early 1980’s, the trend showed that there are roughly 60 % of 
anticancer agents are originated from herbal plant such as curcumin, a phenol 
compound derived from rhizome of Curcuma species that can inhibit carcinogenic 
effect in colorectal cancer and genistein, a phytosterol belongs to flavonoids that 
induced apoptosis in human promyelocytic leukemic cells (Safarzadeh et al, 2014; 
Rahman et 2013). There are more than 177 drugs that have been approved and 
registered for cancer treatment, for example vinca alkaloids including vinblastine and 
vincristine, taxanes including paclitaxel and docetaxel (Benzie and Wachtel-Galor, 
2011; Safarzadeh et al, 2014). Those various natural substances that derived from 
plants have been acknowledged to be able induce apoptosis in several malignant 
cells. Recently, significant attention from plant-derived anticancer agents has gained 
to the apoptotic cell death events and the role of its mechanism in cancer treatment.  
 
The use of herbal plant extracts as herbal medicines has become increasingly 
popular especially in breast cancer treatment. As example, Vernonia amygdalina, a 
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woody shrub that have been reported as anticancer agent that documented by Wong 
et al (2013). The plant demonstrated its potential as an anticancer agents for breast 
cancer treatment by G1/S phase cell cycle arrest in breast cancer cells, specifically 
only towards MCF-7 cells. Two types of alkaloids, pterogynine (PGN) and 
pterogynidine (PGD) from Pterogyne nitens extract could induce apoptosis in breast 
cancer cell line (Duarte et al, 2010). Hseu et al (2006) reported that antiproliferative 
action, growth suppression and promotion of apoptosis in breast cancer cells by 
treatment with Antrodia camphorate. The data obtained from Reddy et al (2013) 
revealed that the death of breast cancer cells incubated with cytotoxic extracts of 
Alpinia scabra may be due to apoptosis induction. Those reported plants also has 
been said contain various phytochemical such as alkaloid, flavonoid, tannin and 
others that could related to their pharmacological benefits (Kamal, 2014).  
 
These medicinal values could no longer be ignored and their mode of action 
in the apoptosis pathway of those reported herbal plants should be well-described. 
Therefore, the need to find a safe and highly effective for breast cancer disease 
remains a big challenge in modern science. One of the most recognized herb to be 




Mistletoe is a semi - parasite of plant. It has been used since long time ago for 
various medicinal purposes (Becker, 1982). Mistletoe plants has been used as a ritual 
or medicinal plants from the past few thousand years. It was first introduced by 
Rudolf Steiner in the form of plant extract for the treatment of malignancies disease 
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(Mansky, 2002). It has been widely used form of complementary and alternative 
medicine for cancer treatment and research into its uses poses the challenges to  
implement this kind of approaches into clinical efficacy thus can be used in complex 
cancer treatment. From recent history, there are various confusing history regarding 
mistletoe extract for having ability to delay the cancer growth. Regardless the risks 
of toxicity, old folks have used mistletoe as a therapeutic for various sickness such as 
haemorrhage, syphilis, heart disease and gout (Hyun et al, 1998). Mistletoe 
preparations are harvested from several host-tree species for example pine, apple, 
oak, fur, maple, poplar and hawthorn (Mansky, 2002). In Europe, white berry of 
mistletoe have been used as traditional curative for cancer, hypertension and diabetes 
(Bussing, 2000). The anticancer property of mistletoe extract has been claimed due 
to presence of lectins (Franz, 1986), viscotoxins (Romagnoli et al, 2000) and 
alkaloids (Zhou et al, 2010).  
 
According to Mabberley (2008), the name mistletoe is not only applicable to 
the genus Viscum but also to genus Dendrophthoe. Although several species in the 
Loranthaceae family occur in many rural and disturbed sites, often on exotic or 
cultivated hosts, D. pentandra (L.) Miq is the most common genera that can be found 
easily in urban parks and garden and on street trees as well as roadside tress of semi-
rural areas (Start, 2011). 
 
2.7.1 Dendrophthoe pentandra 
 
Several different local names have been used in various countries such as 
“benalu” in Indonesia and “dedalu” in Malaysia regardless its common name is 
